Ionis Pharmaceuticals
IONS
IONS
204 hedge funds and large institutions have $3.91B invested in Ionis Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 61 increasing their positions, 75 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
204
Holders Change
+31
Holders Change %
+17.92%
% of All Funds
6.62%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.16%
New
46
Increased
61
Reduced
75
Closed
13
Calls
$40.4M
Puts
$58.5M
Net Calls
-$18M
Net Calls Change
-$24.6M
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
$399M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
$35.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$638M |
| 4 |
PC
PointState Capital
New York
|
$27.2M |
| 5 |
CCI
Columbus Circle Investors
|
$25.1M |
Top Sellers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
$1.47M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
$13.8M |
| 3 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
$270M |
| 4 |
Millennium Management
New York
|
$9.77M |
| 5 |
Wells Fargo
San Francisco,
California
|
$29.4M |
